Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to compare the efficacy of inhaled ciclesonide in pre-school
children. Ciclesonide will be inhaled once daily, using one of three dose levels and tested
versus placebo. The study duration consists of a baseline period (2 to 4 weeks) and a
treatment period (24 weeks). The study will provide further data on safety and tolerability
of ciclesonide.